array(40) {
  [0]=>
  string(4) "8960"
  ["article_id"]=>
  string(4) "8960"
  [1]=>
  string(77) "Why companies need to simplify medtech maintenance compliance ahead of EU MDR"
  ["article_title"]=>
  string(77) "Why companies need to simplify medtech maintenance compliance ahead of EU MDR"
  [2]=>
  string(150) "Mark Homer, senior vice president global customer success and head of corporate development for software company, ServiceMax, explains why field servi"
  ["short_description"]=>
  string(150) "Mark Homer, senior vice president global customer success and head of corporate development for software company, ServiceMax, explains why field servi"
  [3]=>
  string(263) "Mark Homer, senior vice president global customer success and head of corporate development for software company, ServiceMax, explains why field service management could prove essential when the EU’s Medical Devices Regulation (MDR) is introduced."
  ["description"]=>
  string(263) "Mark Homer, senior vice president global customer success and head of corporate development for software company, ServiceMax, explains why field service management could prove essential when the EU’s Medical Devices Regulation (MDR) is introduced."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(65) "https://www.medicalplasticsnews.com/news/de-risking-the-machines/"
  ["blog_url"]=>
  string(65) "https://www.medicalplasticsnews.com/news/de-risking-the-machines/"
  [15]=>
  string(19) "2020-04-01 16:44:59"
  ["add_date"]=>
  string(19) "2020-04-01 16:44:59"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8794"
  ["article_id"]=>
  string(4) "8794"
  [1]=>
  string(82) "Y-mAbs Announces Submission of Naxitamab Biologics License Application to U.S. FDA"
  ["article_title"]=>
  string(82) "Y-mAbs Announces Submission of Naxitamab Biologics License Application to U.S. FDA"
  [2]=>
  string(150) "NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq"
  ["short_description"]=>
  string(150) "NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq"
  [3]=>
  string(240) "NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical biopharmaceutical company focused on the development and..."
  ["description"]=>
  string(240) "NEW YORK, April 01, 2020 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a late-stage clinical biopharmaceutical company focused on the development and..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(173) "https://www.drugs.com/nda/naxitamab_200401.html?utm_source=ddc&utm_medium=rss&utm_campaign=Y-mAbs+Announces+Submission+of+Naxitamab+Biologics+License+Application+to+U.S.+FDA"
  ["blog_url"]=>
  string(173) "https://www.drugs.com/nda/naxitamab_200401.html?utm_source=ddc&utm_medium=rss&utm_campaign=Y-mAbs+Announces+Submission+of+Naxitamab+Biologics+License+Application+to+U.S.+FDA"
  [15]=>
  string(19) "2020-04-01 08:04:30"
  ["add_date"]=>
  string(19) "2020-04-01 08:04:30"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:39"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8820"
  ["article_id"]=>
  string(4) "8820"
  [1]=>
  string(165) "Fujifilm Announces the Start of a Phase III Clinical Trial of Influenza Antiviral Drug Avigan (favipiravir) on COVID-19 in Japan and Commits to Increasing Production"
  ["article_title"]=>
  string(165) "Fujifilm Announces the Start of a Phase III Clinical Trial of Influenza Antiviral Drug Avigan (favipiravir) on COVID-19 in Japan and Commits to Increasing Production"
  [2]=>
  string(155) "TOKYO, March 31, 2020 ―FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced today the initiation of a phase III clinical trial "
  ["short_description"]=>
  string(155) "TOKYO, March 31, 2020 ―FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced today the initiation of a phase III clinical trial "
  [3]=>
  string(249) "TOKYO, March 31, 2020 ―FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced today the initiation of a phase III clinical trial to evaluate the safety and efficacy of influenza antiviral drug “Avigan Tablet”..."
  ["description"]=>
  string(249) "TOKYO, March 31, 2020 ―FUJIFILM Toyama Chemical Co., Ltd. (President: Junji Okada) has announced today the initiation of a phase III clinical trial to evaluate the safety and efficacy of influenza antiviral drug “Avigan Tablet”..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/fujifilm-announces-start-phase-iii-clinical-trial-influenza-antiviral-avigan-favipiravir-covid-19-18505.html?utm_source=ddc&utm_medium=rss&utm_campaign=Fujifilm+Announces+the+Start+of+a+Phase+III+Clinical+Trial+of+Influenza+Antiviral+Drug+Avigan+%28favipiravir%2"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/fujifilm-announces-start-phase-iii-clinical-trial-influenza-antiviral-avigan-favipiravir-covid-19-18505.html?utm_source=ddc&utm_medium=rss&utm_campaign=Fujifilm+Announces+the+Start+of+a+Phase+III+Clinical+Trial+of+Influenza+Antiviral+Drug+Avigan+%28favipiravir%2"
  [15]=>
  string(19) "2020-04-01 03:04:24"
  ["add_date"]=>
  string(19) "2020-04-01 03:04:24"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8984"
  ["article_id"]=>
  string(4) "8984"
  [1]=>
  string(75) "how do I interrupt a senior colleague’s monologue during my meeting?"
  ["article_title"]=>
  string(75) "how do I interrupt a senior colleague’s monologue during my meeting?"
  [2]=>
  string(150) "A reader writes: I would love some feedback/advice for how to deal with a particularly annoying colleague in a different department. We work with this"
  ["short_description"]=>
  string(150) "A reader writes: I would love some feedback/advice for how to deal with a particularly annoying colleague in a different department. We work with this"
  [3]=>
  string(1498) "
A reader writes: I would love some feedback/advice for how to deal with a particularly annoying colleague in a different department. We work with this department to handle legal stuff for our group, so we have to liaise with him occasionally (and for important things). However, he is a terrible communicator. Every time we meet […]
&#nl
&#nl
You may also like:
&#nl
&#nl
my coworker keeps hijacking team meetings
&#nl
I talk too much in meetings!
&#nl
what can I do about a senior coworker who always misses meetings with me?
&#nl
&#nl
&#nl
&#nl
how do I interrupt a senior colleague’s monologue during my meeting? was originally published by Alison Green on Ask a Manager.
&#nl"
  ["description"]=>
  string(1498) "
A reader writes: I would love some feedback/advice for how to deal with a particularly annoying colleague in a different department. We work with this department to handle legal stuff for our group, so we have to liaise with him occasionally (and for important things). However, he is a terrible communicator. Every time we meet […]
&#nl
&#nl
You may also like:
&#nl
&#nl
my coworker keeps hijacking team meetings
&#nl
I talk too much in meetings!
&#nl
what can I do about a senior coworker who always misses meetings with me?
&#nl
&#nl
&#nl
&#nl
how do I interrupt a senior colleague’s monologue during my meeting? was originally published by Alison Green on Ask a Manager.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "5"
  ["category"]=>
  string(1) "5"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "50"
  ["rss_id"]=>
  string(2) "50"
  [14]=>
  string(107) "https://www.askamanager.org/2020/03/how-do-i-interrupt-a-senior-colleagues-monologue-during-my-meeting.html"
  ["blog_url"]=>
  string(107) "https://www.askamanager.org/2020/03/how-do-i-interrupt-a-senior-colleagues-monologue-during-my-meeting.html"
  [15]=>
  string(19) "2020-04-01 02:29:49"
  ["add_date"]=>
  string(19) "2020-04-01 02:29:49"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:25"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:25"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8807"
  ["article_id"]=>
  string(4) "8807"
  [1]=>
  string(73) "COVID-19 medicines delivery scheme in Wales to include logistics software"
  ["article_title"]=>
  string(73) "COVID-19 medicines delivery scheme in Wales to include logistics software"
  [2]=>
  string(150) "The Welsh government has announced that DBS-checked volunteers will be used to help community pharmacists deliver medicines to vulnerable patients, an"
  ["short_description"]=>
  string(150) "The Welsh government has announced that DBS-checked volunteers will be used to help community pharmacists deliver medicines to vulnerable patients, an"
  [3]=>
  string(259) "The Welsh government has announced that DBS-checked volunteers will be used to help community pharmacists deliver medicines to vulnerable patients, and a software system will be installed in every pharmacy to ensure there is an audit trail for the deliveries."
  ["description"]=>
  string(259) "The Welsh government has announced that DBS-checked volunteers will be used to help community pharmacists deliver medicines to vulnerable patients, and a software system will be installed in every pharmacy to ensure there is an audit trail for the deliveries."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(152) "https://www.pharmaceutical-journal.com/news-and-analysis/news/covid-19-medicines-delivery-scheme-in-wales-to-include-logistics-software/20207865.article"
  ["blog_url"]=>
  string(152) "https://www.pharmaceutical-journal.com/news-and-analysis/news/covid-19-medicines-delivery-scheme-in-wales-to-include-logistics-software/20207865.article"
  [15]=>
  string(19) "2020-03-31 23:49:00"
  ["add_date"]=>
  string(19) "2020-03-31 23:49:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:36:41"
  ["create_at"]=>
  string(19) "2020-04-12 16:36:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8977"
  ["article_id"]=>
  string(4) "8977"
  [1]=>
  string(65) "SHL buyout looks to advance self-injection drug delivery offering"
  ["article_title"]=>
  string(65) "SHL buyout looks to advance self-injection drug delivery offering"
  [2]=>
  string(150) "With the acquisition of Weibel, SHL Medical looks to the development of novel drug delivery systems for self-administration, answering a need for impr"
  ["short_description"]=>
  string(150) "With the acquisition of Weibel, SHL Medical looks to the development of novel drug delivery systems for self-administration, answering a need for impr"
  [3]=>
  string(188) "With the acquisition of Weibel, SHL Medical looks to the development of novel drug delivery systems for self-administration, answering a need for improved patient-centricity in the sector."
  ["description"]=>
  string(188) "With the acquisition of Weibel, SHL Medical looks to the development of novel drug delivery systems for self-administration, answering a need for improved patient-centricity in the sector."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(133) "https://www.outsourcing-pharma.com/Article/2020/03/31/SHL-Medical-acquires-Weibel?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(133) "https://www.outsourcing-pharma.com/Article/2020/03/31/SHL-Medical-acquires-Weibel?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-31 23:26:00"
  ["add_date"]=>
  string(19) "2020-03-31 23:26:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:24"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8961"
  ["article_id"]=>
  string(4) "8961"
  [1]=>
  string(84) "3D Systems asks additive manufacturing community to help provide necessary resources"
  ["article_title"]=>
  string(84) "3D Systems asks additive manufacturing community to help provide necessary resources"
  [2]=>
  string(150) "3D Systems has pledged its support to help medical device manufacturers and hospitals bridge the supply chain gap for resources to help overcome the C"
  ["short_description"]=>
  string(150) "3D Systems has pledged its support to help medical device manufacturers and hospitals bridge the supply chain gap for resources to help overcome the C"
  [3]=>
  string(202) "3D Systems has pledged its support to help medical device manufacturers and hospitals bridge the supply chain gap for resources to help overcome the COVID-19 pandemic, including PPE and medical devices."
  ["description"]=>
  string(202) "3D Systems has pledged its support to help medical device manufacturers and hospitals bridge the supply chain gap for resources to help overcome the COVID-19 pandemic, including PPE and medical devices."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/3d-systems-asks-additive-manufacturing-community-to-help-pro/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/3d-systems-asks-additive-manufacturing-community-to-help-pro/"
  [15]=>
  string(19) "2020-03-31 23:05:02"
  ["add_date"]=>
  string(19) "2020-03-31 23:05:02"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8858"
  ["article_id"]=>
  string(4) "8858"
  [1]=>
  string(129) "NovuHealth Launches Rapid Response Engagement Solution to Help  Health Plans Communicate with Members During COVID-19 Pandemic"
  ["article_title"]=>
  string(129) "NovuHealth Launches Rapid Response Engagement Solution to Help  Health Plans Communicate with Members During COVID-19 Pandemic"
  [2]=>
  string(131) "Solution Shares Vital Information and Plan Resources with Members Solution Shares Vital Information and Plan Resources with Members"
  ["short_description"]=>
  string(131) "Solution Shares Vital Information and Plan Resources with Members Solution Shares Vital Information and Plan Resources with Members"
  [3]=>
  string(142) "Solution Shares Vital Information and Plan Resources with Members 
Solution Shares Vital Information and Plan Resources with Members
"
  ["description"]=>
  string(142) "Solution Shares Vital Information and Plan Resources with Members 
Solution Shares Vital Information and Plan Resources with Members
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(196) "http://www.globenewswire.com/news-release/2020/03/31/2009280/0/en/NovuHealth-Launches-Rapid-Response-Engagement-Solution-to-Help-Health-Plans-Communicate-with-Members-During-COVID-19-Pandemic.html"
  ["blog_url"]=>
  string(196) "http://www.globenewswire.com/news-release/2020/03/31/2009280/0/en/NovuHealth-Launches-Rapid-Response-Engagement-Solution-to-Help-Health-Plans-Communicate-with-Members-During-COVID-19-Pandemic.html"
  [15]=>
  string(19) "2020-03-31 22:00:00"
  ["add_date"]=>
  string(19) "2020-03-31 22:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:59"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9003"
  ["article_id"]=>
  string(4) "9003"
  [1]=>
  string(87) "&#nlUpdate on treatments and vaccines against COVID-19 under development , , 31/03/2020"
  ["article_title"]=>
  string(87) "&#nlUpdate on treatments and vaccines against COVID-19 under development , , 31/03/2020"
  [2]=>
  string(169) "&#nl&#nl          &#nl              &#nl&#nl&#nlSupporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMAâ"
  ["short_description"]=>
  string(169) "&#nl&#nl          &#nl              &#nl&#nl&#nlSupporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMAâ"
  [3]=>
  string(205) "&#nl&#nl          &#nl              &#nl&#nl&#nlSupporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMA’s top priority to help save..."
  ["description"]=>
  string(205) "&#nl&#nl          &#nl              &#nl&#nl&#nlSupporting the rapid development and approval of effective and safe treatments for and vaccines against COVID-19 is EMA’s top priority to help save..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "88"
  ["rss_id"]=>
  string(2) "88"
  [14]=>
  string(96) "
https://www.ema.europa.eu/en/news/update-treatments-vaccines-against-covid-19-under-development"
  ["blog_url"]=>
  string(96) "
https://www.ema.europa.eu/en/news/update-treatments-vaccines-against-covid-19-under-development"
  [15]=>
  string(19) "2020-03-31 22:00:00"
  ["add_date"]=>
  string(19) "2020-03-31 22:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:45"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:45"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8962"
  ["article_id"]=>
  string(4) "8962"
  [1]=>
  string(80) "Complications and facets: Innovating polymer coatings to improve medical devices"
  ["article_title"]=>
  string(80) "Complications and facets: Innovating polymer coatings to improve medical devices"
  [2]=>
  string(135) "Arjun Luthra, commercial director, BioInteractions, explains how the company is innovating polymer coatings to improve medical devices."
  ["short_description"]=>
  string(135) "Arjun Luthra, commercial director, BioInteractions, explains how the company is innovating polymer coatings to improve medical devices."
  [3]=>
  string(135) "Arjun Luthra, commercial director, BioInteractions, explains how the company is innovating polymer coatings to improve medical devices."
  ["description"]=>
  string(135) "Arjun Luthra, commercial director, BioInteractions, explains how the company is innovating polymer coatings to improve medical devices."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(66) "https://www.medicalplasticsnews.com/news/complications-and-facets/"
  ["blog_url"]=>
  string(66) "https://www.medicalplasticsnews.com/news/complications-and-facets/"
  [15]=>
  string(19) "2020-03-31 21:15:28"
  ["add_date"]=>
  string(19) "2020-03-31 21:15:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:21"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:21"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8978"
  ["article_id"]=>
  string(4) "8978"
  [1]=>
  string(50) "MedPharm donates hand sanitizer to combat COVID-19"
  ["article_title"]=>
  string(50) "MedPharm donates hand sanitizer to combat COVID-19"
  [2]=>
  string(147) "The company has shifted production to manufacture sanitizer, intended to protect healthcare providers and other essential workers from coronavirus."
  ["short_description"]=>
  string(147) "The company has shifted production to manufacture sanitizer, intended to protect healthcare providers and other essential workers from coronavirus."
  [3]=>
  string(147) "The company has shifted production to manufacture sanitizer, intended to protect healthcare providers and other essential workers from coronavirus."
  ["description"]=>
  string(147) "The company has shifted production to manufacture sanitizer, intended to protect healthcare providers and other essential workers from coronavirus."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(166) "https://www.outsourcing-pharma.com/Article/2020/03/31/Contract-manufacturer-makes-hand-sanitizer-to-fight-COVID-19?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(166) "https://www.outsourcing-pharma.com/Article/2020/03/31/Contract-manufacturer-makes-hand-sanitizer-to-fight-COVID-19?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-31 21:15:00"
  ["add_date"]=>
  string(19) "2020-03-31 21:15:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:42:24"
  ["create_at"]=>
  string(19) "2020-04-12 16:42:24"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8859"
  ["article_id"]=>
  string(4) "8859"
  [1]=>
  string(67) "Press Release Oncology Venture publishes the Annual Report for 2019"
  ["article_title"]=>
  string(67) "Press Release Oncology Venture publishes the Annual Report for 2019"
  [2]=>
  string(165) "Hørsholm, Denmark March 31, 2020 – Oncology Venture A/S (“OV” or the Company) today publishes the Annual Report for 2019. The Annual Report is "
  ["short_description"]=>
  string(165) "Hørsholm, Denmark March 31, 2020 – Oncology Venture A/S (“OV” or the Company) today publishes the Annual Report for 2019. The Annual Report is "
  [3]=>
  string(398) "
Hørsholm, Denmark March 31, 2020 – Oncology Venture A/S (“OV” or the Company) today publishes the Annual Report for 2019. The Annual Report is available as an attached document and on the company´s website (www.oncologyventure.com/investors/financial-reports-corporate-documents). Below is a summary of the Annual Report.
"
  ["description"]=>
  string(398) "
Hørsholm, Denmark March 31, 2020 – Oncology Venture A/S (“OV” or the Company) today publishes the Annual Report for 2019. The Annual Report is available as an attached document and on the company´s website (www.oncologyventure.com/investors/financial-reports-corporate-documents). Below is a summary of the Annual Report.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(138) "http://www.globenewswire.com/news-release/2020/03/31/2009226/0/en/Press-Release-Oncology-Venture-publishes-the-Annual-Report-for-2019.html"
  ["blog_url"]=>
  string(138) "http://www.globenewswire.com/news-release/2020/03/31/2009226/0/en/Press-Release-Oncology-Venture-publishes-the-Annual-Report-for-2019.html"
  [15]=>
  string(19) "2020-03-31 21:06:00"
  ["add_date"]=>
  string(19) "2020-03-31 21:06:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-04-12 16:41:59"
  ["create_at"]=>
  string(19) "2020-04-12 16:41:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}